AU2002231077A1 - Novel compounds - Google Patents

Novel compounds

Info

Publication number: AU2002231077A1
Authority: AU; Australia
Prior art keywords: novel compounds; novel; compounds
Prior art date: 2000-12-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002231077A

Inventor

Pankaj Agarwal

Marian Birkeland

John P. Cogswell

Karen F. Kabnick

Ying-Ta Lai

Shelby A. Martensen

Safia K. Rizvi

Randall F. Smith

Jay C. Strum

Qing Xie

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Ltd

Glaxo Group Ltd

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Ltd

Glaxo Group Ltd

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-19

Filing date

2001-12-17

Publication date

2002-07-01

2001-12-17 Application filed by SmithKline Beecham Ltd, Glaxo Group Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd

2002-07-01 Publication of AU2002231077A1 publication Critical patent/AU2002231077A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Heart & Thoracic Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Toxicology (AREA)
Zoology (AREA)
Cardiology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2002231077A 2000-12-19 2001-12-17 Novel compounds Abandoned AU2002231077A1 (en)

Applications Claiming Priority (17)

Application Number	Priority Date	Filing Date	Title
US25671000P	2000-12-19	2000-12-19
US60256710		2000-12-19
US25704800P	2000-12-20	2000-12-20
US60257048		2000-12-20
US26048201P	2001-01-09	2001-01-09
US60260482		2001-01-09
US26492201P	2001-01-30	2001-01-30
US60264922		2001-01-30
US26679701P	2001-02-06	2001-02-06
US60266797		2001-02-06
US27698801P	2001-03-19	2001-03-19
US60276988		2001-03-19
US28153501P	2001-04-04	2001-04-04
US60281535		2001-04-04
US28962201P	2001-05-08	2001-05-08
US60289622		2001-05-08
PCT/US2001/049232 WO2002050105A1 (en)	2000-12-19	2001-12-17	Novel compounds

Publications (1)

Publication Number	Publication Date
AU2002231077A1 true AU2002231077A1 (en)	2002-07-01

Family

ID=27575289

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002231077A Abandoned AU2002231077A1 (en)	2000-12-19	2001-12-17	Novel compounds

Country Status (4)

Country	Link
EP (1)	EP1343813A4 (en)
JP (1)	JP2004531214A (en)
AU (1)	AU2002231077A1 (en)
WO (1)	WO2002050105A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030149238A1 (en) *	2000-02-14	2003-08-07	Pankaj Agarwal	Novel compounds
US20030139572A1 (en) *	2000-03-24	2003-07-24	Panjak Agarwal	Novel compounds
US20020111302A1 (en) *	2000-11-30	2002-08-15	Y. Tom Tang	Novel nucleic acids and polypeptides
US6664091B2 (en)	2000-12-18	2003-12-16	Millennium Pharmaceuticals, Inc.	53010, a human carboxylesterase family member and uses thereof
AU2002324058A1 (en) *	2001-08-21	2003-03-10	Bayer Healthcare Ag	Regulation of human g protein-couple receptor kinase
JP2005508168A (en) *	2001-10-24	2005-03-31	ミレニアム・ファーマシューティカルズ・インコーポレイテッド	69583 and 85924, novel human protein kinase family members and their use
WO2003046006A1 (en) *	2001-11-27	2003-06-05	Bayer Healthcare Ag	Polynucleotides encoding nexin-related serine protease inhibitor
FR2837492B1 (en) *	2002-03-21	2007-07-20	Commissariat Energie Atomique	APICAL IODE TRANSPORTER AND ITS APPLICATIONS
AU2003226131A1 (en)	2002-03-28	2003-10-13	Bristol-Myers Squibb Company	Novel human cell surface protein with immunoglobulin folds, bgs-19
US20040053304A1 (en)	2002-06-05	2004-03-18	Case Western Reserve University	Methods and compositions for detecting cancers
AU2003243151A1 (en)	2002-08-16	2004-03-03	Agensys, Inc.	Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
WO2005095637A1 (en) *	2004-03-02	2005-10-13	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with mixed lineage kinase 4 beta (mlk4 beta)
WO2005103240A1 (en) *	2004-04-24	2005-11-03	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with casein kinase 1, delta, isoform 1 (csnk1d iso 1)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW562807B (en) *	1997-04-01	2003-11-21	Chugai Pharmaceutical Co Ltd	Novel secretory membrane protein
JP2002514925A (en) *	1997-07-01	2002-05-21	ヒューマンジノームサイエンシーズ，インコーポレイテッド	19 human secreted proteins
SE9801617D0 (en) *	1998-05-08	1998-05-08	Karolinska Innovations Ab	New compound
AU1459100A (en) *	1998-11-20	2000-06-13	Zymogenetics Inc.	Testis-specific cystatin-like protein cystatin t
WO2001094388A2 (en) *	2000-06-05	2001-12-13	Zymogenetics, Inc.	Zcys6: a member of the cystatin superfamily

2001
- 2001-12-17 AU AU2002231077A patent/AU2002231077A1/en not_active Abandoned
- 2001-12-17 WO PCT/US2001/049232 patent/WO2002050105A1/en not_active Ceased
- 2001-12-17 JP JP2002551998A patent/JP2004531214A/en active Pending
- 2001-12-17 EP EP01991347A patent/EP1343813A4/en not_active Withdrawn

Also Published As

Publication number	Publication date
JP2004531214A (en)	2004-10-14
WO2002050105A1 (en)	2002-06-27
EP1343813A4 (en)	2004-11-17
EP1343813A1 (en)	2003-09-17

Publication	Publication Date	Title
AU2002218266A1 (en)	2002-07-25	Novel indanylidene compounds
AU2002225730A1 (en)	2002-05-27	Compounds
AU2001292518A1 (en)	2002-04-08	Novel compounds
AU2001265089A1 (en)	2002-01-14	Rc-timer scheme
AU2001266345A1 (en)	2002-04-11	Five-membered-ring compound
AU2002359165A1 (en)	2003-06-30	Novel compounds
AU2001239765A1 (en)	2001-08-27	Novel compounds
AUPQ661800A0 (en)	2000-05-04	Insulin-potentiating compounds
AU2001246998A1 (en)	2001-10-23	Novel compounds
AU2001281965A1 (en)	2002-01-30	Novel 6-phenylphenanthridines
AU2001253362A1 (en)	2001-10-30	Novel compounds
AU2001265871A1 (en)	2001-11-07	Substituted sulfonylaminopyrimidines
AU2001258255A1 (en)	2001-11-29	Substituted benzoylcyclohexenones
AU2002231077A1 (en)	2002-07-01	Novel compounds
AU2001254731A1 (en)	2001-10-23	Substituted phenyluracils
AU2001256964A1 (en)	2001-10-08	Novel compounds
AU2002225724A1 (en)	2002-07-08	Motilide compounds
AU2002217285A1 (en)	2002-07-01	Compounds
AU2001230689A1 (en)	2001-08-07	Novel compounds
AU2002216060A1 (en)	2002-06-11	Novel compounds
AU2002221923A1 (en)	2002-06-11	Novel compounds
AUPQ575300A0 (en)	2000-03-16	New compound
AU2001276890A1 (en)	2002-01-21	Novel compounds
AU2002223604A1 (en)	2002-07-11	Substituted phenyluracils
AU2001258760A1 (en)	2001-11-26	Novel thiophenamide compounds